Tech Company Financing Transactions
PlaqueTec Funding Round
Private investors participated in a $5 million capital raise for PlaqueTec. The round was announced on 4/28/2026.
Transaction Overview
Company Name
Announced On
4/28/2026
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programs
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Maia Building (B270), Babraham Research Campus
Cambridge, CB22 3AT
UK
Cambridge, CB22 3AT
UK
Phone
Undisclosed
Website
Email Address
Overview
PlaqueTec is identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD). CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Martin Stapleton
Chief Scientific Officer
Diane Proudfoot
General Manager
Simon Williams
Browse more venture capital transactions:
Prev: 4/28/2026: dehaze venture capital transaction
Next: 4/28/2026: Ineffable Intelligence venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs